Home

Discover

Sign up for free to listen for longer

Get unlimited radio, access to exclusive and original podcasts and non-stop music stations.

Control the way you listen to your favourite music, podcasts and radio.

Already have an account?

Log in

Home

Discover

Sign up for free to listen for longer

Get unlimited radio, access to exclusive and original podcasts and non-stop music stations.

Control the way you listen to your favourite music, podcasts and radio.

Already have an account?

Log in

Freakonomics Radio

Freakonomics Radio

Discover the hidden side of everything with Stephen J. Dubner, co-author of the Freakonomics books. Each week, Freakonomics Radio tells you things you always thought you knew (but didn’t) and things you never thought you wanted to know (but do) — from the economics of sleep to how to become great at just about anything. Dubner speaks with Nobel laureates and provocateurs, intellectuals and entrepreneurs, and various other underachievers.

Follow
Share
Episodes
You might also like
56 min•
Today

615. Is Ozempic as Magical as It Sounds?

In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy. SOURCES:Ezekiel Emanuel, vice provost for Global Initiatives, co-director of the Health Transformation Institute, and professor at the University of Pennsylvania Perelman School of Medicine. RESOURCES:"Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal," by Margot Sanger-Katz (The New York Times, 2024)."International Coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches," by Johan L. Dellgren, and Govind Persad, and Ezekiel J. Emanuel (The Lancet, 2024).The Coming Wave: Technology, Power, and the Twenty-first Century's Greatest Dilemma, by Mustafa Suleyman (2023)."The Significance of Blockbusters in the Pharmaceutical Industry," by Alexander Schuhmacher, Markus Hinder, Nikolaj Boger, Dominik Hartl, and Oliver Gassmann (Nature Reviews Drug Discovery, 2022).Reinventing American Health Care: How the Affordable Care Act Will Improve Our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System, by Ezekiel J. Emanuel (2014)."Why I Hope to Die at 75," by Ezekiel J. Emanuel (The Atlantic, 2014)."Direct-to-Consumer Advertising of Pharmaceuticals," by Ziad F. Gellad and Kenneth W. Lyles (The American Journal of Medicine, 2014).Brothers Emanuel: A Memoir of an American Family, by Ezekiel J. Emanuel (2013)."Bounds in Competing Risks Models and the War on Cancer," by Bo E. Honoré and Adriana Lleras-Muney (Econometrica, 2006). EXTRAS:"How to Fix Medical Research," by People I (Mostly) Admire (2024)."The Suddenly Diplomatic Rahm Emanuel," by Freakonomics Radio (2023)."Ari Emanuel Is Never Indifferent," by Freakonomics Radio (2023)."Who Pays for Multimillion-Dollar Miracle Cures?" by Freakonomics, M.D. (2023)."Who Gets the Ventilator?" by Freakonomics Radio (2020).

615. Is Ozempic as Magical as It Sounds?
Mark as played
Share
Share
51 min•
5 Dec

614. Is the U.S. Sleeping on Threats from Russia and China?

John J. Sullivan, a former State Department official and U.S. ambassador, says yes: “Our politicians aren’t leading — Republicans or Democrats.” He gives a firsthand account of a fateful Biden-Putin encounter, talks about his new book Midnight in Moscow, and predicts what a second Trump term means for Russia, Ukraine, China — and the U.S. SOURCES:John Sullivan, former U.S. Deputy Secretary of State and former U.S. Ambassador to Russia.  RESOURCES:Midnight in Moscow: A Memoir from the Front Lines of Russia's War Against the West, by John Sullivan (2024)."The ‘Deathonomics’ Powering Russia’s War Machine," by Georgi Kantchev and Matthew Luxmoore (The Wall Street Journal, 2024).War, by Bob Woodward (2024)."On the Record: The U.S. Administration’s Actions on Russia," by Alina Polyakova and Filippos Letsas (Brookings, 2019)."Why Economic Sanctions Still Do Not Work," by Robert A. Pape (International Security, 1998). EXTRAS:"The Suddenly Diplomatic Rahm Emanuel," by Freakonomics Radio (2023).

614. Is the U.S. Sleeping on Threats from Russia and China?
Mark as played
Share
Share
1 hr, 1 min•
28 Nov

613. Dying Is Easy. Retail Is Hard.

Macy’s wants to recapture its glorious past. The author of the Wimpy Kid books wants to rebuild his dilapidated hometown. We just want to listen in. (Part two of a two-part series.) SOURCES:Mark Cohen, former professor and director of retail studies at Columbia Business School.Will Coss, vice president and executive producer of Macy’s Studios.Jeff Kinney, author, cartoonist, and owner of An Unlikely Story Bookstore and Café.Tony Spring, chairman and C.E.O. of Macy’s Inc. RESOURCES:"Macy’s Discovers Employee Hid Millions in Delivery Expenses," by Jordyn Holman and Danielle Kaye (The New York Times, 2024)."NBC Ready to Pay Triple to Gobble Up Thanksgiving Parade Broadcast Rights," by Joe Flint (The Wall Street Journal, 2024)."How Macy’s Set Out to Conquer the Department Store Business — and Lost," by Daphne Howland (Retail Dive, 2022).An Unlikely Story Bookstore and Café. EXTRA:"Can the Macy's Parade Save Macy's?" series by Freakonomics Radio (2024).

613. Dying Is Easy. Retail Is Hard.
Mark as played
Share
Share
53 min•
21 Nov

612. Is Macy’s Thanksgiving Parade Its Most Valuable Asset?

The 166-year-old chain, which is fighting extinction, calls the parade its “gift to the nation.” With 30 million TV viewers, it’s also a big moneymaker. At least we think it is — Macy’s is famously tight-lipped about parade economics. We try to loosen them up. (Part one of a two-part series.)Please take our audience survey at freakonomics.com/survey. SOURCES:John Cheney, carpenter at Macy’s Studios.Will Coss, vice president and executive producer of Macy’s Studios.Jeff Kinney, author, cartoonist, and owner of An Unlikely Story Bookstore and Café.Kevin Lynch, vice president of global helium at Messer.Jen Neal, executive vice president of live events and specials for NBCUniversal EntertainmentTony Spring, chairman and C.E.O. of Macy's Inc.Jessica Tisch, commissioner of the New York City Department of Sanitation; incoming commissioner of the New York City Police Department.Dawn Tolson, executive director of Citywide Event Coordination and Management and the Street Activity Permit Office for the City of New York. RESOURCES:Macy's: The Store. The Star. The Story., by Robert M. Grippo (2009).History of Macy's of New York, 1853-1919: Chapters in the Evolution of the Department Store, by Ralph M. Hower (1943).Macy's Thanksgiving Day Parade. EXTRA:The Economics of Everyday Things. 

612. Is Macy’s Thanksgiving Parade Its Most Valuable Asset?
Mark as played
Share
Share
59 min•
14 Nov

611. Fareed Zakaria on What Just Happened, and What Comes Next

After a dramatic election, Donald Trump has returned from exile. We hear what to expect at home and abroad — and what to do if you didn’t vote for Trump. SOURCE:Fareed Zakaria, journalist and author. RESOURCES:"The Most Dangerous Moment Since the Cold War," by Fareed Zakaria (The Washington Post, 2024)."America’s Failed Approach to Iran Can’t Really Be Called a Strategy," by Fareed Zakaria (The Washington Post, 2024).Age of Revolutions: Progress and Backlash from 1600 to the Present, by Fareed Zakaria (2024). EXTRAS:"Are We Living Through the Most Revolutionary Period in History?" by Freakonomics Radio (2024)."Are Private Equity Firms Plundering the U.S. Economy?" by Freakonomics Radio (2023).

611. Fareed Zakaria on What Just Happened, and What Comes Next
Mark as played
Share
Share
43 min•
7 Nov

610. Who Wins and Who Loses Once the U.S. Legalizes Weed?

Some people want the new cannabis economy to look like the craft-beer movement. Others are hoping to build the Amazon of pot. And one expert would prefer a government-run monopoly. We listen in as they fight it out. (Part four of a four-part series.) SOURCES:Jon Caulkins, professor of operations research and public policy at Carnegie Mellon University.Adam Goers, senior vice president of The Cannabist Company and chairperson of the Coalition for Cannabis Scheduling Reform.Yasmin Hurd, director of the Addiction Institute at Mount Sinai.Jared Polis, governor of Colorado.Ryan Stoa, associate professor of law at Louisiana State University. RESOURCES:"Prevalence of and Trends in Current Cannabis Use Among U.S. Youth and Adults, 2013–2022," by Delvon T. Mattingly, Maggie K. Richardson, and Joy L. Hart (Drug and Alcohol Dependence Reports, 2024)."Colorado’s Weed Market Is Coming Down Hard and It’s Making Other States Nervous," by Mona Zhang (Politico, 2024)."Reducing Alcohol Consumption, the Nordic Way: Alcohol Monopolies, Marketing Bans and Higher Taxation," by the World Health Organization (2023)."Economic Benefits and Social Costs of Legalizing Recreational Marijuana," by Jason P. Brown, Elior Cohen, and Alison Felix (Federal Reserve Bank of Kansas City Research Working Paper, 2023)."Competition in the Markets for Beer, Wine, and Spirits," by the United States Department of the Treasury (2022)."Alcohol Monopolies," by Robin Room (Scottish Health Action on Alcohol Problems, 2021)."Craft Beer Is the Strangest, Happiest Economic Story in America," by Derek Thompson (The Atlantic, 2018)."Marijuana Discontinuation, Anxiety Symptoms, and Relapse to Marijuana," by Marcel O. Bonn-Miller and Rudolf H. Moos (Addictive Behaviors, 2009). EXTRAS:"Is America Switching from Booze to Weed?" series by Freakonomics Radio (2024)."Why Do Your Eyeglasses Cost $1,000?" by Freakonomics Radio (2024)."Should You Trust Private Equity to Take Care of Your Dog?" by Freakonomics Radio (2023)."Is Dialysis a Test Case of Medicare for All?" by Freakonomics Radio (2021).

610. Who Wins and Who Loses Once the U.S. Legalizes Weed?
Mark as played
Share
Share